Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A
Clinical trial NCT01480180 · COMPLETED
Trial details
- NCT number
- NCT01480180
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-30
- Primary completion
- 2018-12-10
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.